Expert Opinion on Emerging Drugs, Volume 25, Issue 4 (2020)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Emerging Drugs, Volume 25, Issue 4 (2020)

See all volumes and issues
Vol 29, 2024 Vol 28, 2023 Vol 27, 2022 Vol 26, 2021 Volume 25, 2020 Vol 24, 2019 Vol 23, 2018 Vol 22, 2017 Vol 21, 2016 Vol 20, 2015 Vol 19, 2014 Vol 18, 2013 Vol 17, 2012 Vol 16, 2011 Vol 15, 2010 Vol 14, 2009 Vol 13, 2008 Vol 12, 2007 Vol 11, 2006 Vol 10, 2005 Vol 9, 2004 Vol 8, 2003 Vol 7, 2002 Vol 6, 2001 Vol 6, 2001 Vol 5, 2000 Vol 4, 1999 Vol 3, 1998 Vol 2, 1997
Download citations Download PDFs Download issue

Editorial

Editorial
Bruton’s tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis
Edgar Carnero Contentti & Jorge Correale
Pages: 377-381
Published online: 21 Sep 2020
First Page PreviewforBruton’s tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis | Full Text | References | PDF (740.1 KB) | EPUB
  • 6033 Views
  • 28 CrossRef citations
  • 0Altmetric
Free Access

Review

Emerging corticosteroid delivery platforms for treatment of diabetic macular edema
Janika Shah, Anagha Vaze, Timothy Tang Lee Say, Mark C Gillies & Samantha Fraser-Bell
Pages: 383-394
Published online: 31 Aug 2020
AbstractforEmerging corticosteroid delivery platforms for treatment of diabetic macular edema | Full Text | References | PDF (607.4 KB) | EPUB
  • 189 Views
  • 2 CrossRef citations
  • 0Altmetric
Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD)
Marco Pozzi, Silvana Bertella, Erika Gatti, Gabriëlla G. A. M. Peeters, Carla Carnovale, Stefania Zambrano & Maria Nobile
Pages: 395-407
Published online: 25 Sep 2020
AbstractforEmerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD) | Full Text | References | PDF (412.5 KB) | EPUB
  • 36286 Views
  • 16 CrossRef citations
  • 0Altmetric
Open Access
Emerging drugs for the treatment of acromegaly
Claudia Campana, Giuliana Corica, Federica Nista, Francesco Cocchiara, Giulia Graziani, Keyvan Khorrami, Marta Franco, Mara Boschetti, Diego Ferone & Federico Gatto
Pages: 409-417
Published online: 23 Sep 2020
AbstractforEmerging drugs for the treatment of acromegaly | Full Text | References | PDF (906.2 KB) | EPUB
  • 355 Views
  • 1 CrossRef citations
  • 0Altmetric
New drugs under development for COPD
Federica Lo Bello, Philip M. Hansbro, Chantal Donovan, Irene Coppolino, Sharon Mumby, Ian M. Adcock & Gaetano Caramori
Pages: 419-431
Published online: 29 Sep 2020
AbstractforNew drugs under development for COPD | Full Text | References | PDF (443.6 KB) | EPUB
  • 890 Views
  • 12 CrossRef citations
  • 0Altmetric
Emerging drugs for the treatment of Waldenström macroglobulinemia
Fotiou Despina, Dimopoulos Meletios Athanasios & Kastritis Efstathios
Pages: 433-444
Published online: 21 Sep 2020
AbstractforEmerging drugs for the treatment of Waldenström macroglobulinemia | Full Text | References | PDF (1.8 MB) | EPUB
  • 188 Views
  • 3 CrossRef citations
  • 0Altmetric
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer
Domenica Lorusso, Valentina Ceni, Margherita Muratore, Vanda Salutari, Camilla Nero, Antonella Pietragalla, Francesca Ciccarone, Vittoria Carbone, Gennaro Daniele & Giovanni Scambia
Pages: 445-453
Published online: 20 Oct 2020
AbstractforEmerging role of immune checkpoint inhibitors in the treatment of ovarian cancer | Full Text | References | PDF (348 KB) | EPUB
  • 509 Views
  • 12 CrossRef citations
  • 0Altmetric
Emerging drugs for the treatment of scleroderma: a review of recent phase 2 and 3 trials
David Roofeh, Alain Lescoat & Dinesh Khanna
Pages: 455-466
Published online: 26 Oct 2020
AbstractforEmerging drugs for the treatment of scleroderma: a review of recent phase 2 and 3 trials | Full Text | References | PDF (1.3 MB) | EPUB
  • 334 Views
  • 6 CrossRef citations
  • 0Altmetric
Emerging drugs for the treatment of epidermolysis bullosa
Matthias Titeux, Mathilde Bonnet des Claustres, Araksya Izmiryan, Helene Ragot & Alain Hovnanian
Pages: 467-489
Published online: 14 Dec 2020
AbstractforEmerging drugs for the treatment of epidermolysis bullosa | Full Text | References | PDF (6.8 MB) | EPUB
  • 417 Views
  • 7 CrossRef citations
  • 0Altmetric
Cell cycle inhibitors for the treatment of acute myeloid leukemia: a review of phase 2 & 3 clinical trials
Nadya Jammal, Caitlin R. Rausch, Tapan M. Kadia & Naveen Pemmaraju
Pages: 491-499
Published online: 19 Nov 2020
AbstractforCell cycle inhibitors for the treatment of acute myeloid leukemia: a review of phase 2 & 3 clinical trials | Full Text | References | PDF (375.2 KB) | EPUB
  • 208 Views
  • 5 CrossRef citations
  • 0Altmetric
Emerging immune checkpoint inhibitors for the treatment of head and neck cancers
Sarah E. Green, Michael G. McCusker & Ranee Mehra
Pages: 501-514
Published online: 17 Dec 2020
AbstractforEmerging immune checkpoint inhibitors for the treatment of head and neck cancers | Full Text | References | PDF (1.1 MB) | EPUB
  • 415 Views
  • 7 CrossRef citations
  • 0Altmetric
Emerging drugs for the treatment of chronic myelomonocytic leukemia
Jorge Ramos Perez & Guillermo Montalban-Bravo
Pages: 515-529
Published online: 13 Dec 2020
AbstractforEmerging drugs for the treatment of chronic myelomonocytic leukemia | Full Text | References | PDF (2.1 MB) | EPUB
  • 264 Views
  • 4 CrossRef citations
  • 0Altmetric
Behçet’s disease uveitis: is there a need for new emerging drugs?
Ilknur Tugal-Tutkun & Pinar Çakar Özdal
Pages: 531-547
Published online: 30 Nov 2020
AbstractforBehçet’s disease uveitis: is there a need for new emerging drugs? | Full Text | References | PDF (434 KB) | EPUB
  • 244 Views
  • 12 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update
Joshua Winograd et al.
Review Article | Published online: 6 Jun 2024
Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer’s disease
Hui Jue Wang et al.
Review Article | Published online: 1 Jun 2024
Emerging drugs for the treatment of short bowel syndrome
Tristan Frau et al.
Review Article | Published online: 23 May 2024
Aticaprant: (a κ-opioid receptor antagonist) for major depressive disorder
Elliot Hampsey et al.
Review Article | Published online: 8 May 2024
Open Access
View all latest articles